Evidence map›Paper›PMID 21735318›Full record

ArticleNeurotoxicity research2011

Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance.

Li Rebekah Feng, Kathleen A Maguire-Zeiss

Open access · greenAbstract read
In one paragraph

Article in Neurotoxicity research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Parkinson's disease.Sub-cellular biochemistry · 2012
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Li Rebekah FengDepartment of Neuroscience and Interdisciplinary Program in Neuroscience, Georgetown University Medical Center, 3970 Reservoir Rd NW, Washington, DC 20057, USA.
Kathleen A Maguire-Zeiss
Georgetown University Medical Center · US

Funding

Toxicant, oxidative injury, dopamine & synuclein in PDR01ES014470 · NIEHS · UNIVERSITY OF ROCHESTER · PI MAGUIRE-ZEISS, KATHLEEN ANNE · 2007 to 2011
$1.7M
NIEHS NIH HHS R01 ES014470NIEHS NIH HHS R01ES014470
6 · The paper itself

Abstract

We have previously demonstrated that α-synuclein overexpression increases the membrane conductance of dopaminergic-like cells. Although α-synuclein is thought to play a central role in the pathogenesis of several neurodegenerative diseases including Parkinson's disease, multiple system atrophy, and diffuse Lewy body disease, the mechanism of action is not completely understood. In this study, we sought to determine whether multiple factors act together with α-synuclein to engender cell vulnerability through an augmentation of membrane conductance. In this article, we employed a cell model that mimics dopaminergic neurons coupled with α-synuclein overexpression and oxidative stressors. We demonstrate an enhancement of α-synuclein-induced toxicity in the presence of combined treatment with dopamine and paraquat, two molecules known to incite oxidative stress. In addition, we show that combined dopamine and paraquat treatment increases the expression of heme oxygenase-1, an antioxidant response protein. Finally, we demonstrate for the first time that combined treatment of dopaminergic cells with paraquat and dopamine enhances α-synuclein-induced leak channel properties resulting in increased membrane conductance. Importantly, these increases are most robust when both paraquat and dopamine are present suggesting the need for multiple oxidative insults to augment α-synuclein-induced disruption of membrane integrity.

Indexed as

alpha-SynucleinAnalysis of VarianceAnimalsCell Line, TumorDopamineDopamine AgentsDopamine Plasma Membrane Transport ProteinsDoxycyclineDrug InteractionsGene Expression RegulationGreen Fluorescent ProteinsHeme Oxygenase-1HerbicidesHumansLevodopaMembrane Potentialsalpha-SynucleinDopamineDopamine AgentsDopamine Plasma Membrane Transport ProteinsDoxycyclinegreen fluorescent protein, Aequorea victoriaGreen Fluorescent ProteinsHeme Oxygenase-1HerbicidesLevodopaNerve Tissue ProteinsParaquatTetrazolium SaltsThiazolesthiazolyl blueTubulinTyrosine 3-MonooxygenaseVesicular Monoamine Transport Proteins

Identifiers

PMID21735318
PMCPMC3175296
OpenAlexW2085390580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.